[Federal Register Volume 81, Number 31 (Wednesday, February 17, 2016)]
[Notices]
[Pages 8079-8081]
[FR Doc No: 2016-03153]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-4462]

Point of Care Prothrombin Time/International Normalized Ratio
Devices for Monitoring Warfarin Therapy; Public Workshop; Request for
Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
following public workshop entitled ``Point of Care Prothrombin Time/
International Normalized Ratio Devices for Monitoring Warfarin
Therapy.'' The purpose of this workshop is to discuss and receive input
from stakeholders regarding approaches to the analytical and clinical
validation of point of care (POC) Prothrombin Time/International
Normalized Ratio (PT/INR) in vitro diagnostic devices for improved
clinical management of warfarin therapy in addition to describing the
FDA's process for facilitating the development of safe and effective
POC and patient self-testing PT/INR devices. The goal of the workshop
is to seek and identify potential solutions to address the scientific
and regulatory challenges associated with POC PT/INR devices to ensure
safety and effectiveness. The public workshop on ``Point of Care

Prothrombin Time/International Normalized Ratio Devices for Monitoring
Warfarin Therapy'' that had been scheduled for January 25, 2016, was
postponed due to unanticipated weather conditions and rescheduled for
March 18, 2016.

DATES: The public workshop will be held on March 18, 2016, from 8 a.m.
to 5 p.m. This public workshop is being rescheduled because of a
postponed meeting announced in the Federal Register of December 15,
2015 (80 FR 77641), originally scheduled for January 25, 2016. Submit
either electronic or written comments on the public workshop by April
18, 2016.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2015-N-4462 for ``Point of Care Prothrombin Time/International
Normalized Ratio Devices for Monitoring Warfarin Therapy.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
    The public workshop will be held at FDA's White Oak Campus, 10903
New Hampshire Ave., Bldg. 31 Conference Center, Rm. 1503 (the Great
Room), Silver Spring, MD 20993-0002. Entrance for the public meeting
participants (non-FDA employees) is through Building 1 where routine
security check procedures will be performed. For parking and security
information, please refer to: http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.

FOR FURTHER INFORMATION CONTACT:  Rachel Goehe, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave, Bldg. 66, Rm. 5533, Silver Spring, MD 20993,<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    Warfarin, an oral vitamin K antagonist, is a commonly prescribed
anticoagulant drug used to reduce the risk of thromboembolic events.
Warfarin inhibits the synthesis of clotting factors II, VII, IX, and X,
in addition to the naturally occurring endogenous anticoagulant
proteins C and S. The response of individual patients to warfarin is
highly variable because of factors such as diet, age, and interaction
with other drugs. As a consequence, it is important that warfarin
dosage be tailored individually to maintain clinical benefit. The PT
test is used to determine a patient's clotting time, which the Clinical
and Laboratory Standards Institute defines as the time in seconds
required for a fibrin clot to form in a plasma sample after tissue
thromboplastin and an optimal amount of calcium chloride have been
added to the sample. It is well-recognized that a PT result obtained
with one test system cannot be compared to a PT result obtained with
another test system because of the variety of thromboplastins used in
different test systems. Therefore, PT test results are converted into a
standardized unit known as the INR, which was adopted by the World
Health Organization with the intent to reduce intersystem variation in
test results. The INR result is used to monitor patients' response to
warfarin.
    POC PT/INR devices offer an alternative to laboratory-based testing
and venipuncture, enabling a rapid INR determination from a finger
stick sample of whole blood. POC devices can be used in a variety of
settings including, but not limited to, physician's office laboratory,
anti-coagulation clinic, patient bedside, hospital emergency
department, and prescription home use. The purpose of POC PT/INR
testing is to monitor warfarin and to provide immediate information to
physicians about the patient's anticoagulation

status so that this information can be integrated into appropriate
treatment decisions that can improve patient outcomes. POC PT/INR
testing is increasingly being viewed as a testing modality with
performance expectations similar to that of traditional laboratory
testing. From a regulatory standpoint, POC PT/INR devices have been
reviewed and cleared for prescription use under appropriate
professional supervision or prescription home use (patient self-
testing), depending on the claimed intended use. For this workshop,
both settings will be open for discussion.

II. Topics for Discussion at the Public Workshop

    This public workshop will consist of presentations covering the
topics listed in this document. Following the presentations, there will
be a moderated panel discussion where participants will be asked to
provide their perspectives. The workshop panel discussion will focus on
identifying potential solutions to address the scientific and
regulatory challenges associated with POC PT/INR devices. In advance of
the meeting, FDA plans to post a discussion paper outlining FDA's
current thinking on the various topics mentioned in the following list,
and invite comment on this from the community.
    Topics to be discussed at the public workshop include, but are not
limited to, the following:
     Current regulatory process involved with the clearance of
POC PT/INR devices.
     Current benefit/risk balance of POC PT/INR devices.
     Technological differences amongst marketed POC PT/INR
devices, advantages and limitations of each technology, and
comparability of test results obtained using different technologies.
     Challenges associated with correlating results from whole
blood POC PT/INR devices to conventional plasma-based laboratory tests.
     Appropriate study design for validation and usability
studies from the perspectives of the Agency, manufacturers and end
users to help improve our understanding of the accuracy, reliability
and safety of POC PT/INR devices.
     Types of quality control and the test system elements
assessed by the controls.
     Challenges associated with different sample matrices
(venous, fingerstick, arterial).
    Registration: Registration is free and available on a first-come,
first-served basis. Persons interested in attending this public
workshop must register online by 4 p.m., March 10, 2016. Early
registration is recommended because facilities are limited and,
therefore, FDA may limit the number of participants from each
organization. If time and space permits, onsite registration on the day
of the public workshop will be provided beginning at 7 a.m.
    If you need special accommodations due to a disability, please
contact Susan Monahan, Center for Devices and Radiological Health,
Office of Communication and Education,<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>no later than March 4, 2016.
    To register for the public workshop, please visit FDA's Medical
Devices News & Events--Workshops & Conferences calendar at http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm.
(Select this public workshop from the posted events list.) Please
provide complete contact information for each attendee, including name,
title, affiliation, address, email, and telephone number. Those without
Internet access should contact Susan Monahan (contact for special
accommodations) to register. Registrants will receive confirmation
after they have been accepted. You will be notified if you are on a
waiting list.
    Streaming Webcast of the Public Workshop: This public workshop will
also be Webcast. The Webcast link will be available on the workshop Web
page after March 10, 2016. Please visit FDA's Medical Devices News &
Events--Workshops & Conferences calendar at http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm. (Select
this public workshop from the posted events list.) If you have never
attended a Connect Pro event before, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a
quick overview of the Connect Pro program, visit http://www.adobe.com/go/connectpro_overview. FDA has verified the Web site addresses, as of
the date this document publishes in the Federal Register, but Web sites
are subject to change over time.
    Transcripts: Please be advised that as soon as a transcript is
available, it will be accessible at http://www.regulations.gov. It may
be viewed at the Division of Dockets Management (see ADDRESSES). A
transcript will also be available in either hardcopy or on CD-ROM,
after submission of a Freedom of Information request. The Freedom of
Information office address is available on the Agency's Web site at
http://www.fda.gov. A link to the transcripts will also be available
approximately 45 days after the public workshop on the Internet at
http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm. (Select this public workshop from the posted events list).

    Dated: February 9, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-03153 Filed 2-16-16; 8:45 am]
 BILLING CODE 4164-01-P


SECTION 612. SAFE ALTERNATIVES POLICY.

  (a)  Policy.- To the  maximum extent practicable, class I and

class  II  substances shall  be  replaced  by chemicals, product

substitutes, or alternative  manufacturing processes that reduce

overall risks to human health and the environment.

  (b) Reviews and Reports.-  The Administrator shall-

       (1)  in consultation  and  coordination  with  interested

     members of the  public  and the  heads of  relevant Federal

     agencies and   departments,  recommend   Federal  research

     programs  and  other  activities  to  assist in  identifying

     alternatives to the use  of class I and class  II substances

     as refrigerants,  solvents, fire retardants, foam blowing

     agents, and other commercial applications and in achieving a

     transition to such  alternatives,  and, where  appropriate,

     seek to maximize the use  of Federal research facilities and

     resources to assist users of class I and class II substances

in identifying and developing  alternatives to the use of such  substances as refrigerants, solvents, fire retardants, foam   blowing agents, and other commercial applications;

       (2)  examine in consultation and coordination with the

     Secretary of Defense and the heads of other relevant Federal

     agencies and departments,  including  the General  Services

     Administration, Federal procurement practices with respect

     to class I and class II substances and recommend measures to

     promote the transition by the Federal Government, as expedi-

     tiously as possible, to the use of safe substitutes;

       (3)    specify    initiatives,    including    appropriate

     intergovernmental, international, and commercial information

     and technology transfers, to promote the development and use

     of  safe substitutes  for class I  and class  II substances,

     including  alternative  chemicals, product  substitutes, and

     alternative manufacturing processes; and

       (4) maintain a public  clearinghouse of alternative chemi-

     cals,  product  substitutes,  and alternative  manufacturing

     processes that are available for  products and manufacturing

     processes which use class I and class II substances.

  (c) Alternatives for Class I or II Substances.- Within 2 years

after  enactment of  the Clean  Air Act  Amendments of  1990, the

Administrator shall promulgate rules under this section providing

that it  shall be  unlawful to  replace any class  I or  class II

substance with any  substitute substance which  the Administrator

determines may present  adverse effects  to human  health or  the

environment,   where   the   Administrator  has   identified   an

alternative to such replacement that-

       (1)  reduces the overall  risk  to human  health  and the

     environment; and

       (2) is currently or potentially available.

The Administrator shall publish a list of (A) the substitutes

prohibited under this subsection for  specific uses and  (B) the

safe alternatives identified under  this subsection for  specific

uses.

  (d)   Right  To  Petition.-    Any   person  may  petition  the

Administrator to add a substance to the lists under subsection

(c) or to remove a substance  from either  of  such lists.  The

Administrator shall grant or deny the petition within 90 days

after receipt of any such  petition. If the Administrator denies

the petition,  the Administrator shall publish  an explanation of

why  the petition  was denied. If  the Administrator  grants such

petition the Administrator shall publish such revised list within

6 months thereafter.  Any petition under this subsection shall

include a  showing by the petitioner  that there are data  on the

substance adequate to support  the petition. If the Administrator

determines that information on the substance is not sufficient to

make a determination  under this  subsection, the  Administrator

shall use any authority available to the Administrator, under any

law   administered  by   the   Administrator,  to   acquire  such

information.

  (e) Studies and Notification. -  The Administrator shall require

any person who produces  a chemical substitute  for a  class I

substance to provide the Administrator with such person's

unpublished health and  safety  studies on  such substitute  and

require producers to notify  the Administrator not  less than 90

days before new  or  existing  chemicals  are  introduced  into

interstate commerce for significant new uses as substitutes for a

class  I substance.  This subsection shall be subject to section

114(c).

[42 U.S.C. 7671k]


                 United States Environmental Protection Agency                                                                        Docket Index for                             [EPA-R09-OAR-2014-0711]                      Proposed and Direct Final FR Notice                                          Approval and Promulgation of Implementation Plans; Revisions to the Nevada State Implementation Plan; Stationary Source Permits

Category I.  State Implementation Plan Revision Submittals and Related Materials

I-A SIP submittal letter and enclosures from NDEP dated January 3, 2014 I-B SIP submittal withdrawal letter from NDEP dated January 28, 2014 I-C SIP submittal letter and enclosures from NDEP dated June 5, 2014 I-D Supplemental submittal letter and enclosure from NDEP dated July 15, 2014 I-E SIP submittal reinstatement letter from NDEP dated September 17, 2014

Category II.  Federal Register Notices Relied on for Direct Final Rule

II-A 62 FR 38652 (July 18, 1997) II-B 71 FR 15040 (March 27, 2006) II-C 71 FR 61144 (October 17, 2006)  II-D 73 FR 16436 (March 27, 2008) II-E 73 FR 66964 (November 12, 2008) II-F 75 FR 6474 (February 9, 2010) II-G 75 FR 35520 (June 22, 2010) II-H 77 FR 28424 (May 14, 2012) II-I 77 FR 38557 (June 28, 2012) II-J 77 FR 59321 (September 27, 2012) II-K 78 FR 3086 (January 15, 2013)  II-L 78 FR 47191 (August 5, 2013)

Category III.	Other Relevant Documents

III-A Existing SIP NAC section 445B.22097 III-B Existing SIP NAC section 445B.308 III-C Existing SIP NAC section 445B.311 III-D Submitted NAC section 445B.308 (LCB File No. R042-13) III-E Submitted NAC sections 445B.22097 and 445B.311 (LCB File No. R145-13) III-F Summary Minutes of SEC Meeting of December 4, 2013 III-G Summary Minutes of SEC Meeting of May 2, 2014 (Draft)

IV.	EPA Rulemaking Documents

IV-A Federal Register Notice of Proposed Rulemaking dated October 21, 2014 IV-B Federal Register Notice of Direct Final Rulemaking dated October 21, 2014


[Federal Register Volume 79, Number 198 (Tuesday, October 14, 2014)]
[Notices]
[Pages 61630-61632]
[FR Doc No: 2014-24297]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. PF14-19-000]

Downeast Liquefaction, LLC; Notice of Intent To Prepare an
Environmental Impact Statement for the Planned Downeast LNG Import-
Export Project, Request for Comments on Environmental Issues and Notice
of Public Scoping Meeting

    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) will prepare an environmental impact statement (EIS) that
will discuss the environmental impacts of the Downeast LNG Export
Project involving construction and operation of facilities by Downeast
Liquefaction, LLC (Downeast Liquefaction) in Washington County, Maine.
The Commission will use this EIS in its decision-making process to
determine whether the project is in the public convenience and
necessity.
    This notice announces the opening of the scoping process the
Commission and its cooperating agencies will use to gather input from
the public and interested agencies on the project. Your input will help
the Commission staff determine what issues they need to evaluate in the
EIS. Please note that the scoping period will close on November 3,
2014.
    You may submit comments in written form or verbally. Further
details on how to submit written comments are in the Public
Participation section of this notice. In lieu of or in addition to
sending written comments, the Commission invites you to attend the
public scoping meeting scheduled as follows: FERC Public Scoping
Meeting, Downeast LNG Import-Export Project, October 22, 2014, 7:00
p.m. local time, Robbinston Grade School, 904 US Route 1, Robbinston,
ME 04671.
    This notice is being sent to the Commission's current environmental
mailing list for this project. State and local government
representatives should notify their constituents of this planned
project and encourage them to comment on their areas of concern.
    If you are a landowner receiving this notice, a pipeline company
representative may contact you about the acquisition of an easement to
construct, operate, and maintain the planned pipeline facilities
associated with the project. The company would seek to negotiate a
mutually acceptable agreement. However, if the Commission approves the
project, that approval conveys with it the right of eminent domain for
parcels crossed by the pipeline. Therefore, if easement negotiations
fail to produce an agreement, the pipeline company could initiate
condemnation proceedings where compensation would be determined in
accordance with state law.
    A fact sheet prepared by the FERC entitled ``An Interstate Natural
Gas Facility On My Land? What Do I Need To Know?'' is available for
viewing on the FERC Web site (www.ferc.gov). This fact sheet addresses
a number of typically-asked questions, including the use of eminent
domain and how to participate in the Commission's proceedings.

Summary of the Planned Project

    Downeast Liquefaction plans to develop, construct, and operate
liquefied natural gas (LNG) terminal facilities that would convert the
proposed Downeast LNG Import Project (Docket Nos. CP07-52-000, CP07-53-
000, and CP07-53-001) into a bidirectional import-export LNG terminal
and pipeline capable of producing 3 million metric tonnes per annum
(mtpa) of LNG and 100 million standard cubic feet per day (mmscfd) of
regasified LNG.
    The Downeast LNG Import-Export Project would consist of the
following facilities:

Marine Facilities and Transfer Lines:
     The Import-Export Project would involve no changes to the
marine facilities and transfer lines that were proposed and evaluated
for the Import Project.

LNG Storage and Regasification:
     The Import-Export Project would include a single LNG
storage tank with a nominal usable storage capacity of 160,000 cubic
meters. The storage tank design and location would be the same as the
southern-most LNG storage tank proposed for the Import Project. The
northern-most LNG storage tank proposed for the Import Project would
not be required for the Import-Export Project.

     The Import-Export Project would include two Submerged
Combustion Vaporizers used for regasification of LNG during import
mode, of which one would be used during operation while the second
would be a backup.

LNG Liquefaction Facilities:
     feed gas pretreatment systems;
     one LNG liquefaction train with a nominal design capacity
of 3 mtpa;
     refrigerant storage and handling;
     refrigerant compression systems; and
     refrigerant cooling system.

Pipeline Facilities:
     The pipeline for the Import-Export Project would be 24
inches in diameter, a change from 30 inches in diameter as proposed for
the Import Project. The pipeline route and construction work areas
would remain the same as proposed for the Import Project.

Ancillary Facilities:
     onsite power generation to support operation of the
terminal in export mode; and
     utilities, infrastructure, and support systems within the
terminal site would be revised for the Import-Export Project to
accommodate addition of liquefaction capabilities.
    The general location of the project facilities is shown in appendix
1.\1\
---------------------------------------------------------------------------

    \1\ The appendices referenced in this notice will not appear in
the Federal Register. Copies of the appendices were sent to all
those receiving this notice in the mail and are available at
www.ferc.gov using the link called ``eLibrary'' or from the
Commission's Public Reference Room, 888 First Street NE.,
Washington, DC 20426, or call<PHONE_NUMBER>. For instructions on
connecting to eLibrary, refer to the last page of this notice.
---------------------------------------------------------------------------

Land Requirements for Construction

    The planned LNG Export Project facilities would be constructed
entirely within the 80-acre site of the proposed Downeast LNG Import
Project, at Mill Cove in Robbinston, Maine.

The EIS Process

    The Commission intends to publish its review of the Downeast LNG
Export Project as a supplement to the previous review of the Downeast
LNG Import Project (Docket Nos. CP07-52-000, CP07-53-000, and CP07-53-
001), to be considered together as the Downeast LNG Import-Export
Project.
    NEPA requires the Commission to take into account the environmental
impacts that could result from an action whenever it considers the
issuance of a Certificate of Public Convenience and Necessity. NEPA
also requires us \2\ to discover and address concerns the public may
have about proposals. This process is referred to as scoping. The main
goal of the scoping process is to focus the analysis in the EIS on the
important environmental issues. By this notice, the Commission requests
public comments on the scope of the issues to address in the EIS. We
will consider all filed comments during the preparation of the EIS.
However, comments should focus on issues specific to the Downeast LNG
Export Project and not issues previously addressed for the Downeast LNG
Import Project.
---------------------------------------------------------------------------

    \2\ ``We,'' ``us,'' and ``our'' refer to the environmental staff
of the Commission's Office of Energy Projects.
---------------------------------------------------------------------------

    In the EIS, we will discuss impacts that could occur as a result of
the construction and operation of the planned project under these
general headings:
     Geology and soils;
     water resources, fisheries, and wetlands;
     vegetation and wildlife;
     endangered and threatened species;
     cultural resources;
     land use;
     socioeconomics;
     air quality and noise;
     reliability and safety;
     engineering and design material; and
     direct, indirect, and cumulative environmental impacts.
    We will also evaluate possible alternatives to the planned project
or portions of the project, and make recommendations on how to lessen
or avoid impacts on the various resource areas.
    Although no formal application has been filed, we have already
initiated our NEPA review under the Commission's pre-filing process.
The purpose of the pre-filing process is to encourage early involvement
of interested stakeholders and to identify and resolve issues before
the FERC receives an application. As part of our pre-filing review, we
have begun to contact some federal and state agencies to discuss their
involvement in the scoping process and the preparation of the EIS.
    The Supplemental draft EIS will present our independent analysis of
the issues. We will publish and distribute the Supplemental draft EIS
for public comment. After the comment period, we will consider all
timely comments and revise the document, as necessary, before issuing a
Supplemental final EIS. To ensure we have the opportunity to consider
and address your comments, please carefully follow the instructions in
the Public Participation section beginning on page 6.
    With this notice, we are asking agencies with jurisdiction by law
and/or special expertise with respect to the environmental issues
related to this project to formally cooperate with us in the
preparation of the EIS.\3\ Agencies that would like to request
cooperating agency status should follow the instructions for filing
comments provided under the Public Participation section of this
notice. Currently, the U.S. Army Corps of Engineers (COE), U.S.
Environmental Protection Agency, National Oceanic and Atmospheric
Administration National Marine Fisheries Service, and Maine Department
of Environmental Protection are participating as cooperating agencies
in the preparation of the EIS to satisfy their NEPA responsibilities
related to this project. Also, in accordance with the 2004 Interagency
Agreement on the safety and security review of waterfront import/export
LNG facilities, the U.S. Coast Guard and U.S. Department of
Transportation participate as cooperating agencies. The COE will be in
attendance at the public scoping meeting to gather information for
their independent review process and to answer any public questions.
---------------------------------------------------------------------------

    \3\ The Council on Environmental Quality regulations addressing
cooperating agency responsibilities are at Title 40, Code of Federal
Regulations, Part 1501.6.
---------------------------------------------------------------------------

Consultations Under Section 106 of the National Historic Preservation
Act

    In accordance with the Advisory Council on Historic Preservation's
implementing regulations for section 106 of the National Historic
Preservation Act, we are using this notice to initiate consultation
with applicable State Historic Preservation Office(s) (SHPO), and to
solicit their views and those of other government agencies, interested
Indian tribes, and the public on the project's potential effects on
historic properties.\4\ We will define the project-specific Area of
Potential Effects (APE) in consultation with the SHPO as the project
develops. On natural gas facility projects, the APE at a minimum
encompasses all areas subject to ground disturbance (examples include
construction right-of-way, contractor/pipe storage yards, compressor
stations, and access roads). Our EIS for this project will document our
findings on the impacts on historic properties and summarize the status
of consultations under section 106.
---------------------------------------------------------------------------

    \4\ The Advisory Council on Historic Preservation regulations
are at Title 36, Code of Federal Regulations, Part 800. Those
regulations define historic properties as any prehistoric or
historic district, site, building, structure, or object included in
or eligible for inclusion in the National Register of Historic
Places.

---------------------------------------------------------------------------

Currently Identified Environmental Issues

    We have already identified several issues that we think deserve
attention based on our previous review of the Downeast LNG Import
Project, a preliminary review of the planned Export Project facilities,
and the environmental information provided by Downeast Liquefaction.
This preliminary list of issues may change based on your comments and
our analysis. Issued identified include:
     Potential impacts on wetlands and other aquatic resources
within the LNG terminal site;
     potential impacts from release of ballast water from LNG
carriers during the loading of LNG cargo;
     potential visual effects on surrounding areas;
     potential noise and air emissions impacts from the
addition of natural gas liquefaction facilities; and
     public safety and hazards associated with the liquefaction
and transport of LNG.

Public Participation

    You can make a difference by providing us with your specific
comments or concerns about the project. Since Commission staff will
issue a supplement to the previous environmental documents for the
Downeast LNG Import Project, we do not intend to re-evaluate issues
previously addressed for the LNG Import Project; therefore, comments
are requested on issues specific to the LNG Export Project. Your
comments should focus on the potential environmental effects,
reasonable alternatives, and measures to avoid or lessen environmental
impacts. The more specific your comments, the more useful they will be.
To ensure that your comments are timely and properly recorded, please
send your comments so that the Commission receives them in Washington,
DC on or before November 3, 2014. This is not your only public input
opportunity; please refer to the Environmental Review Process flowchart
in appendix 2.
    For your convenience, there are three methods you can use to submit
your comments to the Commission. In all instances, please reference the
project docket number (PF14-19-000) with your submission. The
Commission encourages electronic filing of comments and has expert
staff available to assist you at<PHONE_NUMBER> or<EMAIL_ADDRESS>    (1) You can file your comments electronically using the eComment
feature located on the Commission's Web site (www.ferc.gov) under the
link to Documents and Filings. This is an easy method for interested
persons to submit brief, text-only comments on a project;
    (2) You can file your comments electronically using the eFiling
feature located on the Commission's Web site (www.ferc.gov) under the
link to Documents and Filings. With eFiling, you can provide comments
in a variety of formats by attaching them as a file with your
submission. New eFiling users must first create an account by clicking
on ``eRegister.'' You must select the type of filing you are making. If
you are filing a comment on a particular project, please select
``Comment on a Filing''; or
    (3) You can file a paper copy of your comments by mailing them to
the following address: Kimberly D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street NE., Room 1A, Washington, DC
20426.

Environmental Mailing List

    The environmental mailing list includes federal, state, and local
government representatives and agencies; elected officials;
environmental and public interest groups; Native American Tribes; other
interested parties; and local libraries and newspapers. This list also
includes all affected landowners (as defined in the Commission's
regulations) who are potential right-of-way grantors, whose property
may be used temporarily for project purposes, or who own homes within
certain distances of aboveground facilities, and anyone who submits
comments on the project. We will update the environmental mailing list
as the analysis proceeds to ensure that we send the information related
to this environmental review to all individuals, organizations, and
government entities interested in and/or potentially affected by the
planned project.
    Copies of the completed Supplemental draft EIS will be sent to the
environmental mailing list for public review and comment. If you would
prefer to receive a paper copy of the document instead of the CD
version or would like to remove your name from the mailing list, please
return the attached Information Request (appendix 3).

Becoming an Intervenor

    Once Downeast Liquefaction files its application with the
Commission, you may want to become an ``intervenor'' which is an
official party to the Commission's proceeding. Intervenors play a more
formal role in the process and are able to file briefs, appear at
hearings, and be heard by the courts if they choose to appeal the
Commission's final ruling. An intervenor formally participates in the
proceeding by filing a request to intervene. Instructions for becoming
an intervenor are in the User's Guide under the ``e-filing'' link on
the Commission's Web site. Please note that the Commission will not
accept requests for intervenor status at this time. You must wait until
the Commission receives a formal application for the project.

Additional Information

    Additional information about the project is available from the
Commission's Office of External Affairs, at (866) 208-FERC, or on the
FERC Web site (www.ferc.gov) using the eLibrary link. Click on the
eLibrary link, click on ``General Search'' and enter the docket number,
excluding the last three digits in the Docket Number field (i.e., PF14-
19-000). Be sure you have selected an appropriate date range. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at<PHONE_NUMBER>, or for TTY,
contact<PHONE_NUMBER>. The eLibrary link also provides access to the
texts of formal documents issued by the Commission, such as orders,
notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. Go to www.ferc.gov/docs-filing/esubscription.asp.
    Finally, public meetings or site visits will be posted on the
Commission's calendar located at www.ferc.gov/EventCalendar/EventsList.aspx along with other related information.

    Dated: October 3, 2014.
 Kimberly D. Bose,
 Secretary.
[FR Doc. 2014-24297 Filed 10-10-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 186 (Thursday, September 25, 2014)]
[Notices]
[Pages 57550-57551]
[FR Doc No: 2014-22803]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER14-2871-000]

Cameron Ridge, LLC; Supplemental Notice That Initial Market-Based
Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding,
of Cameron Ridge, LLC's application for market-based rate authority,
with an accompanying rate schedule, noting that such application
includes a request for blanket authorization, under 18 CFR part 34, of
future issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR Part 34, of future issuances of securities and assumptions of
liability is October 6, 2014.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding(s) are accessible in
the

Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: September 15, 2014.
Kimberly D. Bose,
Secretary.
[FR Doc. 2014-22803 Filed 9-24-14; 8:45 am]
BILLING CODE 6717-01-P